This archived post is for informational purposes.
Drug coated heart stents have been linked to an increased risk of serious and potentially fatal blood clots which could develop years after the stent is implanted. However, there are many individuals who have not experienced a blood clot, heart attack or reclogging of the artery, yet now must remain on Plavix long term after the stent placement. The Saiontz & Kirk, P.A. heart stent lawyers are reviewing potential legal claims on behalf of individuals who must remain on Plavix indefintely, as well a those who suffered a heart attack or reclogging of the artery.
>>INFORMATION: Heart Stent Lawsuits
The manufacturers of drug coated stents, Johnson & Johnson and Boston Scientific, previously indicated that it would only be necessary for individuals to remain on Plavix for three to six months following stent placement. However, they failed to properly research their product or warn about the heart stent problems which could lead to blood clots at the site of the stent months or even years later. As a result, many doctors are now recommending that patients remain on Plavix for a long time to reduce the risk of injury in the future.
The long term use of Plavix can result in unpleasant side effects for users, as well as an increased risk of other injuries such as excessive bleeding, ulcers, gastrointestinal bleeding and a rare blood disorder known as TTP (Thrombotic Thrombocytopenic Purpora)
>>INFORMATION: Plavix side effects
LAWSUITS FOR HEART STENTS AND PLAVIX
For several months, Saiontz & Kirk, P.A. has been representing individuals who suffered a heart attack or reclogging of the artery after receiving a drug coated stent. Our lawyers are now also reviewing potential claims for individuals who have not experienced a blood clot, but now must remain on Plavix long term. To determine if you may have a potential claim, request a stent lawsuit consultation.